Review Article| Volume 361, ISSUE 1, P3-7, January 2021

Hypertension and Hyperthyroidism: Association and Pathogenesis

Published:August 10, 2020DOI:


      Hypertension can cause significant morbidity and reduced life expectancy. Most patients with hypertension have primary hypertension; however, 10 to 15% of patients have secondary hypertension. Endocrine disorders explain approximately 10% of hypertension in all patients, and thyroid disorders account for approximately 1% of cases with hypertension. Hyperthyroidism can cause increased cardiac output, increased systolic blood pressures, and increased levels of renin, angiotensin, and aldosterone. Treatment of hyperthyroidism can cure hypertension in some patients. Consequently, identification of patients with secondary hypertension potentially has important benefits, and understanding secondary hypertension provides a framework for investigating the pathophysiology of hypertension. Clinicians should consider the possibility of hyperthyroidism in patients with hypertension, even in those of more advanced age.



      WHO (World Health Organization), NHANES (National Health and Nutrition Examination Survey), TR (Thyroid hormone receptor)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Fridinger FW
        • Jackson AW
        • Andresen J
        A comparison of results of a national cholesterol and blood pressure screening with the NHANES II study: Implications for further emphasis on reducing cardiovascular risk among Americans.
        J Community Health. 1992; 17: 247-257
        • Cohen DL
        • Townsend RR
        • Angell SY
        • et al.
        The World Health Organization recognizes noncommunicable diseases and raised blood pressure as global health priority for 2025.
        J Clin Hypertens. 2014; 16: 624
        • Whelton PK.
        The elusiveness of population-wide high blood pressure control.
        Annu Rev Public Health. 2015; 36: 109-130
        • O'Shea PM
        • Griffin TP
        • Fitzgibbon M
        Hypertension: the role of biochemistry in the diagnosis and management.
        Clin Chim Acta. 2017; 465: 131-143
        • Anderson GH
        • Blakeman N
        • Streeten DHP
        The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients.
        J Hypertens. 1994; 12: 609-615
        • Young Jr., WF
        • Calhoun DA
        • Lenders JWM
        • et al.
        Screening for endocrine hypertension: an endocrine society Scientific Statement.
        Endocr Rev. 2017; 38: 103-122
        • Prisant LM
        • Gujral JS
        • Mulloy AL
        Hyperthyroidism: a secondary cause of isolated systolic hypertension.
        J Clin Hypertens (Greenwich). 2006; 8: 596-599
        • Marcisz C
        • Jonderko G
        • Kucharz E
        Changes in arterial pressure in patients with hyperthyroidism during therapy.
        Med Sci Monit. 2002; : CR502-CR507
      1. Dennis J, Rivas M, Pena C, et al. The association of hypertension and hyperthyroidism in a subspecialty clinic and a national data base. (unpublished manuscript under review.)

        • Iglesias P
        • Acosta M
        • Sanchez R
        • et al.
        Ambulatory blood pressure monitoring in patients with hyperthyroidism before and after control of thyroid function.
        Clin Endocrinol (Oxf). 2005; 63: 66-72
        • Papaleontiou M
        • Haymart MR.
        Approach to and treatment of thyroid disorders in the elderly.
        Med Clin North Am. 2012; 96: 297-310
        • Rivas AM
        • Larumbe E
        • Thavaraputta S
        • et al.
        Unfavorable socioeconomic factors underlie high rates of hospitalization for complicated thyrotoxicosis in some regions of the United States.
        Thyroid. 2019; 29: 27-35
        • Vasan RS
        • Beiser A
        • Seshadri S
        • et al.
        Residual lifetime risk for developing hypertension in middle-aged women and men.
        JAMA. 2002; 287: 1003-1010
        • Flint AC
        • Conell C
        • Ren X
        • et al.
        Effect of systolic and diastolic blood pressure on cardiovascular outcomes.
        N Engl J Med. 2019; 381: 243-251
        • Lewington S
        • Clarke R
        • Qizilbash N
        • et al.
        Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.
        Lancet. 2002; 360: 1903-1913
        • Zhou D
        • Xi B
        • Zhao M
        • et al.
        Uncontrolled hypertension increases risk of all-cause and cardiovascular disease mortality in US adults: the NHANES III Linked Mortality Study.
        Sci Rep. 2018; 8: 9418
        • Taylor PN
        • Albrecht D
        • Scholz A
        • et al.
        Global epidemiology of hyperthyroidism and hypothyroidism.
        Nat Rev Endocrinol. 2018; 14: 301-316
        • Hollowell JG
        Serum TSH, T4, and Thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).
        J Clin Endocrinol Metab. 2002; 87: 489-499
        • Thavaraputta S
        • Dennis JA
        • Laoveeravat P
        • et al.
        Hypothyroidism and its association with sleep apnea among adults in the United States: NHANES 2007-2008.
        J Clin Endocrinol Metab. 2019; 104: 4990-4997
        • Hurxthal L.
        Blood pressure before and after operation for hyperthyroidism.
        Arch Intern Med. 1931; : 167-181
        • Middeke M
        • Schrader J.
        Nocturnal blood pressure in normotensive subjects and those with white coat, primary, and secondary hypertension.
        BMJ. 1994; 308: 630-632
        • Rosen E
        • Carter-Su C.
        Priniciples of hormone actions.
        in: Melmed S Auchus RJ Goldfine AB Williams Textbook of Endocrinology: Elsevier. Williams Textbook of Endocrinology, Philadelphia, PA2020: 13-41
        • Anyetei-Anum CS
        • Roggero VR
        • Allison LA
        Thyroid hormone receptor localization in target tissues.
        J Endocrinol. 2018; 237: R19-R34
        • Salvatore D
        • Cohen R
        • Kopp PA
        • et al.
        Thyroid Physiology and Diagnostic Evaluation of Patients with Thyroid Disorders.
        in: Melmed S Auchus RJ Goldfine AB Williams Textbook of Endocrinology. Elsevier, Philadelphia, PA2020: 332-363
        • Yen PM.
        Thyroid hormones and 3, 5-diiodothyropropionic acid: new keys for new locks.
        Endocrinology. 2006; 147: 1598-1601
        • Gauthier K
        • Nongenomic Flamant F.
        TRβ-dependent, thyroid hormone response gets genetic support.
        Endocrinology. 2014; 155: 3206-3209
        • Hönes GS
        • Rakov H
        • Logan J
        • et al.
        Noncanonical thyroid hormone signaling mediates cardiometabolic effects in vivo.
        Proc Natl Acad Sci. U S A. 2017; 114: E11323-E11E32
        • Dhaun N
        • Goddard J
        • Kohan DE
        • et al.
        Role of endothelin-1 in clinical hypertension: 20 years on.
        Hypertension. 2008; 52: 452-459
        • Mayyas F
        • Saadeh N
        • Al-Muqbel K
        • et al.
        Plasma endothelin-1 levels are increased in atrial fibrillation patients with hyperthyroidism.
        PLoS One. 2018; 13e0208206
        • Berta E
        • Lengyel I
        • Halmi S
        • et al.
        Hypertension in thyroid disorders.
        Front Endocrinol. 2019; 10: 482
        • Toft AD.
        Thyroid disease and the heart.
        Heart. 2000; 84: 455-460
        • Mazza A
        • Beltramello G
        • Armigliato M
        • et al.
        Arterial hypertension and thyroid disorders: What is important to know in clinical practice?.
        Annales d'Endocrinol. 2011; 72: 296-303
        • Klein I
        • Ojamaa K.
        Thyroid hormone and the cardiovascular system.
        N Engl J Med. 2001; 344: 501-509
        • Muthukumar S
        • Ravikumar K
        • Dhalapathy S
        A prospective comparative study on improvement of hyperthyroid cardiovascular dysfunction in patients undergoing total thyroidectomy versus medical management.
        World J Surg. 2018; 42: 1408-1414
        • LeFevre ML.
        Screening for Thyroid Dysfunction: U.S. preventive services task force recommendation statement.
        Anns Intern Med. 2015; 162: 641